EyePoint, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.38 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 32.76M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic macular edema (DME). The company’s pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was founded in 2000 and is headquartered in Watertown, Massachusetts.
Details
| Name | EyePoint, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 214 |
| Founded | 1987 |
| Ipo Date | 2005-01-27 |
| Ceo | Jay Duker |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US30233G2093 |
| Cusip | 30233G209 |
| Cik | 0001314102 |
| Sic | 3826 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Jay S. Duker M.D. | President, Chief Executive Officer and Director |
| George O. Elston CPA | Executive Vice President and Chief Financial Officer |
| Dr. Ramiro Ribeiro M.D., Ph.D. | Chief Medical Officer |
| Dr. Marcia Sellos-Moura Ph.D. | Chief Scientific Officer |
| Ron I. Honig Esq. | Chief Legal Officer and Company Secretary |
| Jennifer Leonard | Chief People Officer and Senior Vice President of IT |
| David Scott Jones M.A. | Senior Vice President |
| Isabelle Lefebvre | Chief Regulatory Officer |
| Michael J. Maciocio | Chief Manufacturing Officer |
| Michael Campbell | Chief Commercial Officer |
Contact
| Address | 480 Pleasant Street, Suite C-400, Watertown, Massachusetts 02472, United States |
| Phone | 617 926 5000 |
| Website | https://eyepoint.bio |